Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
Ito
Taisuke
T
Hashizume
Hideo
H
Takigawa
Masahiro
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000506:Alopecia Areata / Q000150:complications / Q000473:pathology / Q000628:therapy*; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006197:Hair / Q000254:growth & development*; D006801:Humans; D007167:Immunotherapy; D011565:Psoriasis / Q000150:complications / Q000473:pathology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; D003879:Dermatologic Agents; C020637:squaric acid dibutyl ester; D002117:Calcitriol; C051883:maxacalcitol